Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
about
Targeting LKB1 in cancer - exposing and exploiting vulnerabilitiesOverexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations.Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response.Ηypoxia-inducible factor 1-α promotes colon cell proliferation and migration by upregulating AMPK-related protein kinase 5 under hypoxic conditions.
P2860
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@en
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@nl
type
label
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@en
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@nl
prefLabel
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@en
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
@en
P2093
Gao-Feng Lu
Peng-Yuan Zheng
Yu-Xian Xu
P2860
P2888
P304
P356
10.1007/S13277-013-0735-X
P577
2013-03-21T00:00:00Z